ReviewWorld journal of urology2015

Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?

Axel S Merseburger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.